Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Regulation
4:06
Optimizing the upscaling and outscaling of CAR T-cell therapies
Saskia Rösch
• 6 Apr 2022
2:27
The importance of collaboration in cell and gene therapy development
Delara Motlagh
• 27 Jan 2022
2:27
Improving the scalability of advanced therapies
Delara Motlagh
• 27 Jan 2022
1:41
Strategies for large scale viral vector development
Rachel Legmann
• 27 Jan 2022
2:46
Building collaborative relationships to overcome challenges in the CGT industry
Sharon Brownlow
• 26 Jan 2022
1:04
Regulatory challenges in automating CGT manufacturing
Delara Motlagh
• 27 Jan 2022
1:04
The role of ARM in the cell and gene therapy industry
Michael Lehmicke
• 26 Jan 2022
1:36
The impact of COVID-19 on the advanced therapy sector
Michael Lehmicke
• 26 Jan 2022
0:55
Clinical challenges in developing AAV-based gene therapies
Christopher Reardon
• 27 Jan 2022
4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow
• 26 Jan 2022
1:18
Addressing labor and educational gaps in the CGT industry
Michael Lehmicke
• 26 Jan 2022
1:18
Upscaling cell and gene therapy manufacturing
Michael Lehmicke
• 26 Jan 2022
0:52
A 2022 update of the Alliance for Regenerative Medicine
Janet Lynch Lambert
• 26 Jan 2022
2:14
The need for standardization in cell and gene therapy manufacturing
Michael Lehmicke
• 26 Jan 2022
1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke
• 26 Jan 2022
3:07
Addressing issues in the clinical translation of cell & gene therapies
Janet Lynch Lambert
• 26 Jan 2022
1
2
3
4
Next